Statistics
Publications
1
Citations
18
H-Index
1
Active since
2023
Affiliations
Frontier Medicines (United States)(Current)
Sophie Siemsgluess is an author at Frontier Medicines (United States) specializing in drug discovery, ras-targeted therapies, and kras g12c inhibition.
Publications per year
2023–2023
1
1
1–1 of 1